Schedule 13G ownership disclosure

Immunic Inc

Common Stock, $0.0001 par value · CUSIP: 4525EP101

Event date: 2025-03-31

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • AVIDITY PARTNERS MANAGEMENT LP

    Shares: 6,041,059.00 · Class: 6.6%

  • AVIDITY PARTNERS MANAGEMENT (GP) LLC

    Shares: 6,041,059.00 · Class: 6.6%

  • AVIDITY CAPITAL PARTNERS FUND (GP) LP

    Shares: 6,041,059.00 · Class: 6.6%

  • AVIDITY CAPITAL PARTNERS (GP) LLC

    Shares: 6,041,059.00 · Class: 6.6%

  • AVIDITY PRIVATE MASTER FUND I LP

    Shares: 4,699,532.00 · Class: 5.2%

  • MICHAEL GREGORY

    Shares: 6,041,059.00 · Class: 6.6%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000919574-25-003220
Form type
SCHEDULE 13G/A
Filer
Avidity Partners Management LP
CIK
CIK 1791827
Filed
May 15, 2025
Reporting period
Mar 31, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub